|
|
| Breakthrough Bleeding in OC New Starts |
|
| 35 µg EE OC vs. Two 20 µg EE OCs |
|
|
|
|
| 35 µg
EE |
||
| (Ortho |
||
| Tri-Cyclen) |
||
|
|
|
| 20 µg EE |
||
| (Alesse and |
||
| Mircette) |
||
| No
significant differences |
| Cycle |
| Adapted from Rosenberg MJ
et al. Contraception. 1999;60:321-329. |
